PolyMedix Inc.
170 North Radnor Chester Road
Suite 300
Radnor
Pennsylvania
19465
United States
Tel: 484-624-2400
Fax: 484-624-2401
Website: http://www.polymedix.com/
Email: rmckinley@polymedix.com
165 articles about PolyMedix Inc.
-
Cellceutix Completes Acquisition of PolyMedix Inc. Assets, Immediately Plans Brilacidin™Phase 2b Clinical Trial for Acute Bacterial Skin and Skin Structure Infections (ABSSSI) and Phase 2 Clinical Trial for Oral Mucositis
9/16/2013
-
Cellceutix Buys PolyMedix Inc. Assets From Bankruptcy Court, Gains Ownership of Two Clinical Stage Drugs, Multiple Compounds, and Equipment Assets
9/9/2013
-
PolyMedix Inc. of Radnor Files for Chapter 7 Bankruptcy Protection
4/2/2013
-
PolyMedix Inc. Announces Proposed Public Offering of Common Stock
3/8/2013
-
PolyMedix Inc. Announces Departure of CEO, Appointment of Interim CEO
1/31/2013
-
Landekic Out as CEO of PolyMedix Inc.
1/31/2013
-
PolyMedix Inc. Engages Investment Banker, Amends Credit Facility
1/24/2013
-
PolyMedix Inc. Defensin-Mimetic Anti-Malaria Data Published in Cell Host and Microbe
1/14/2013
-
PolyMedix Inc. Announces Successful Meeting With FDA for Brilacidin
11/16/2012
-
PolyMedix Inc. Reports Third Quarter 2012 Financial Results
11/9/2012
-
PolyMedix Inc. Receives Grant From National Cancer Institute to Study Brilacidin for Oral Mucositis
9/19/2012
-
PolyMedix Inc. Presents New Data on Its Defensin-Mimetic Antibiotics at 52nd Annual ICAAC
9/12/2012
-
PolyMedix Inc. Release: Data Showing Effectiveness of PolyCide Antimicrobial in Surgical Suture Coatings Published in American Chemical Society Journal, Langmuir
9/5/2012
-
PolyMedix Inc. Antibiotic Studies Accepted for Presentation at ICAAC
8/21/2012
-
PolyMedix Inc. Reports Second Quarter 2012 Financial Results
8/9/2012
-
PolyMedix Inc. and University of Pennsylvania Collaborate to Develop New Class of Defensin-Mimetic Antimicrobial Compounds to Treat Malaria
7/31/2012
-
PolyMedix Inc. Outlines Potential Benefits of GAIN Act to Its Antibiotic Development Program
7/13/2012
-
PolyMedix Inc. Receives USAN Approval for Generic Name of Brilacidin for PMX-30063
6/13/2012
-
PolyMedix Inc. Release: New Data on PMX-30063 Presented at American Society of Clinical Oncology Suggest Strong Potential as Treatment for Oral Mucositis
6/4/2012
-
PolyMedix Inc. Stops Studies on Anti-coagulant Reversing Agent
5/11/2012